We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUN icon
4176
Huntsman Corp
HUN
$1.82B
$14K ﹤0.01%
525
-38,144
-99% -$1.08M
INBS icon
4177
Intelligent Bio Solutions
INBS
$4.69M
$14K ﹤0.01%
1
– –
INDY icon
4178
iShares S&P India Nifty 50 Index Fund
INDY
$565M
$14K ﹤0.01%
300
+141
+89% +$6.38K
LIVE icon
4179
Live Ventures
LIVE
$30.7M
$14K ﹤0.01%
233
+19
+9% +$834
MNSB icon
4180
MainStreet Bancshares
MNSB
$172M
$14K ﹤0.01%
624
-435
-41% -$9.35K
MVST icon
4181
Microvast
MVST
$291M
$14K ﹤0.01%
1,045
+131
+14% +$1.55K
NNDM
4182
Nano Dimension
NNDM
$343M
$14K ﹤0.01%
1,676
-5,708
-77% -$42.3K
OVBC icon
4183
Ohio Valley Banc Corp
OVBC
$207M
$14K ﹤0.01%
566
-682
-55% -$16K
OVID icon
4184
Ovid Therapeutics
OVID
$489M
$14K ﹤0.01%
3,524
-5,914
-63% -$23.3K
PARAA
4185
DELISTED
Paramount Global Class A
PARAA
$14K ﹤0.01%
284
+27
+11% +$1.23K
FTH
4186
Faeth Therapeutics
FTH
$736M
$14K ﹤0.01%
71
+42
+145% +$10.4K
SSL icon
4187
Sasol
SSL
$7.38B
$14K ﹤0.01%
+945
New +$15.4K
SSY
4188
DELISTED
SunLink Health Systems
SSY
$14K ﹤0.01%
4,126
+3,906
+1,775% +$11.1K
SWKH
4189
DELISTED
SWK Holdings
SWKH
$14K ﹤0.01%
1,002
+198
+25% +$2.59K
TERN
4190
DELISTED
Terns Pharmaceuticals
TERN
$14K ﹤0.01%
1,180
+566
+92% +$9.64K
TTI icon
4191
TETRA Technologies
TTI
$1.28B
$14K ﹤0.01%
3,135
-14,122
-82% -$46.5K
USAS
4192
Americas Gold and Silver
USAS
$1.73B
$14K ﹤0.01%
+3,831
New +$18.7K
VERU icon
4193
Veru
VERU
$44.5M
$14K ﹤0.01%
179
-921
-84% -$81.1K
YARW
4194
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
$14K ﹤0.01%
4
-1
-20% -$3.96K
XERS icon
4195
Xeris Biopharma Holdings
XERS
$1.46B
$14K ﹤0.01%
3,342
-6,222
-65% -$23.7K
MTVA
4196
MetaVia Inc
MTVA
$7.39M
$14K ﹤0.01%
2
– –
NETI
4197
DELISTED
Eneti Inc.
NETI
$14K ﹤0.01%
772
+270
+54% +$5.4K
OFED
4198
DELISTED
Oconee Federal Financial Corp.
OFED
$14K ﹤0.01%
596
+217
+57% +$5.36K
PFHD
4199
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$14K ﹤0.01%
750
+100
+15% +$1.79K
ASZ
4200
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$14K ﹤0.01%
+1,439
New +$14.1K
166 167
168
169 170

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.